BONESUPPORT'S CEO SELLS SHARES - REMAINS SIGNIFICANT LONG-TERM OWNER

Published: 2023-05-03

BONESUPPORT™, a leading company in orthobiologics for the management of bone injuries, today announce that Emil Billbäck, CEO of BONESUPPORT, has sold 146 000 shares in BONESUPPORT.

After the sale, Emil Billbäck owns 454 425 shares, an increase of 110 195 shares since the beginning of the year, and thus remains with a large private ownership.

"The sale is made solely to cover tax obligations related to a recently completed long-term incentive program and I do not intend to sell additional shares. BONESUPPORT is at an early stage of a very exciting journey, with good future outlook, and I look forward to continuing to develop the company together with the organization and the board”, says Emil Billbäck, CEO of BONESUPPORT.

The transaction has been reported to the Swedish Financial Supervisory Authority in accordance with current regulations.

For more information contact:

BONESUPPORT Holding AB
Emil Billbäck, CEO
+46 (0) 46 286 53 70

Håkan Johansson, CFO
+46 (0) 46 286 53 70
ir@bonesupport.com

Cord Communications
Charlotte Stjerngren
+46 (0) 708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 329 million in 2022. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

BONESUPPORT'S CEO SELLS SHARES - REMAINS SIGNIFICANT LONG-TERM OWNER